Summary

Global Oral Rehydration Solution (ORS) Market Research Report by Formulation (Powder, Liquid, Others), by Age Group (Children, Adults, Geriatrics), by Application (Diarrhoea, Vomiting and Gastrointestinal Disorders, Electrolyte Imbalance, Others), by Distribution Channel (Online Pharmacies, Hypermarkets/Supermarkets, Retail Pharmacies and Drug Stores), and by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035

The Global Oral Rehydration Solution (ORS) market report is projected to grow from USD 1,721.4 million in 2025 to USD 3,546.3 million by 2035, registering a CAGR of 7.6%. Rising awareness of dehydration management and the growing incidence of diarrheal diseases are supporting demand for accessible and effective oral rehydration products.

Stronger Government and Institutional Support
The health authorities at different levels, together with the international bodies in the humanitarian sector and charities are helping to extend Oral Rehydration Solution (ORS) usage through several means including inclusion of the solution in the national health plans, bulk ordering from international suppliers, distributing for free via various NGOs, and carrying out information campaigns on the use of ORS at the local level.

Segment-wise Market Analysis
Formulation
- Powder: Convenient, portable, and widely used formulation.
- Liquid: Ready-to-use option for immediate rehydration.
- Others: Alternative formulations serving specific consumer needs.
Age Group
- Children: High demand for pediatric dehydration management.
- Adults: Supports hydration during illness and fluid loss.
- Geriatrics: Addresses increased dehydration risks among older adults.
Application
- Diarrhea: Remains a major application for ORS products.
- Vomiting and Gastrointestinal Disorders: Replenishes fluids lost during gastrointestinal conditions.
- Electrolyte Imbalance: Helps restore essential electrolytes and hydration.
- Others: Supports additional dehydration-related treatment requirements.
Distribution Channel
- Online Pharmacies: Improve convenient access to ORS products.
- Hypermarkets/Supermarkets: Provide broad consumer access and product visibility.
- Retail Pharmacies and Drug Stores: Remain important channels for immediate ORS purchases.

Regional Analysis
Asia-Pacific region was the largest global Oral Rehydration Solution (ORS) market in 2025 and it will maintain a healthy growth rate till 2035, forecasts the report. Improved healthcare accessibility, increase in the number of dehydration cases, and heightened public health movement in the region will continue supporting the growth of the local market for ORS.

ProlyteORS Expands Consumer Appeal
In 2026, in March, Cipla Health Limited brought out a new Masala Guava-flavored version of its ProlyteORS. The drink combined an ORS formulation recommended by the World Health Organization (WHO) with a taste adapted to Indian taste. The introduction made the product more appealing to consumers while at the same time they could get a scientifically grounded hydration method in a more convenient and pleasurable format.

Advanced Formulations Create Differentiated Value
The development work leading to low-osmolarity solutions, the production of various delicious flavored ORS, the packaging with zinc, and the creation of a portable form in the shape of a gel are all resulting in better therapeutic effect of ORS, higher acceptability, and easier application.

Key Report Attributes
- Market Size 2025: USD 1,721.4 Million
- Market Size 2035: USD 3,546.3 Million
- CAGR (2025-2035): 7.6%
- Base Year: 2024
- Market Forecast Period: 2025-2035

Industry Segmentations Growth
- By Formulation: Powder - 7.4%, Liquid - 8.1%.
- By Age Group: Children - 8.0%, Adults - 7.6%.
- By Application: Diarrhea - 7.4%, Vomiting and Gastrointestinal Disorders - 7.6%.
- By Distribution Channel: Online Pharmacies - 8.4%, Hypermarkets/Supermarkets - 7.6%.

Reasons to Buy
- Analyze global Oral Rehydration Solution market demand trends.
- Assess dehydration management needs supporting ORS market growth.
- Evaluate formulation innovations improving global ORS product adoption.
- Identify pharmacy and online channels expanding ORS accessibility.
- Understand healthcare awareness shaping future Oral Rehydration Solution demand.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 18
2.1 DEFINITION 18
2.2 SCOPE OF THE STUDY 18
2.3 Research Objective 18
2.4 MARKET STRUCTURE 19
3 RESEARCH METHODOLOGY 20
3.1 Overview 20
3.2 DATA flow 22
3.2.1 DATA MINING PROCESS 22
3.3 Purchased Database: 23
3.4 Secondary Sources: 24
3.4.1 SECONDARY RESEARCH DATA FLOW: 25
3.5 Primary Research: 26
3.5.1 PRIMARY RESEARCH DATA FLOW: 27
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 28
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE 28
3.6 Approaches for market size estimation: 29
3.6.1 REVENUE ANALYSIS APPROACH 29
3.7 Data forecasting 30
3.7.1 DATA FORECASTING TYPE 30
3.8 Data modeling 31
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 31
3.8.2 DATA MODELING: 32
3.9 Teams and Analyst Contribution 34
4 MARKET DYNAMICS 36
4.1 INTRODUCTION 36
4.2 Drivers 37
4.2.1 HIGH PREVALENCE OF DIARRHEAL DISEASES AND ASSOCIATED DEHYDRATION IN CHILDREN 37
4.2.2 BROAD CONSUMER ACCESSIBILITY & OTC AVAILABILITY 38
4.2.3 EXPANSION OF INNOVATIVE FORMULATIONS AND PRODUCT DIVERSIFICATION 39
4.2.4 RISING INSTITUTIONAL SUPPORT, GOVERNMENT INITIATIVES & NGO-LED CAMPAIGNS 39
4.3 Restraints 41
4.3.1 COUNTERFEIT, SUBSTANDARD PRODUCTS & REGULATORY INCONSISTENCIES 41
4.3.2 PERSISTENT LOW AWARENESS AND LOW ORS UTILIZATION IN HIGH-BURDEN REGIONS 41
4.3.3 COMPETITION FROM ALTERNATIVE HYDRATION THERAPIES 42
4.4 Opportunities 43
4.4.1 EMERGING MARKET FOR PEDIATRIC CARE 43
4.4.2 TECHNOLOGICAL ADVANCEMENTS IN ORS FORMULATIONS 43
5 MARKET DYNAMICS 44
5.1 Porter's Five Forces Model 44
5.1.1 THREAT OF NEW ENTRANTS 45
5.1.2 BARGAINING POWER OF SUPPLIERS 45
5.1.3 THREAT OF SUBSTITUTES 46
5.1.4 BARGAINING POWER OF BUYERS 46
5.1.5 INTENSITY OF RIVALRY 47
5.2 Consumer Behavior Analysis 48
5.2.1 CONSUMER PROFILE 48
5.2.2 CONSUMER NEEDS AND MOTIVATION 48
5.2.3 BUYING BEHAVIOR 48
5.2.4 FACTORS INFLUENCING PURCHASE DECISIONS 49
5.2.5 CONSUMER PREFERENCES 49
5.3 Market Trends 50
5.4 Product Development Priorities 51
5.4.1 CONSUMER HYDRATION NEEDS AND USAGE OCCASIONS 51
5.4.2 TASTE AND PALATABILITY IMPROVEMENT OPPORTUNITIES 51
5.4.3 PACKAGING INNOVATION PRIORITIES 51
5.4.4 PRODUCT FORMULATION EXPECTATIONS 52
5.4.5 AFFORDABILITY AND ACCESSIBILITY INSIGHTS 52
5.4.6 PRODUCT EXPERIENCE AND USABILITY 52
5.4.7 ADDRESS BARRIERS TO ADOPTION 53
5.5 Communication Strategy 53
5.5.1 TRUST AND CREDIBILITY MANAGEMENT 53
5.5.2 CORE HEALTH MESSAGING IMPROVEMENT 54
5.5.3 AWARENESS AND EDUCATION 54
5.5.4 OCCASION-BASED COMMUNICATION OPPORTUNITIES 54
5.5.5 CUSTOMER PERCEPTION AND SENTIMENT 55
5.5.6 ACTIONABILITY AND PRIORITIZATION 55
6 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION 57
6.1 Overview 57
7 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP 59
7.1 Overview 59
8 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION 61
8.1 Overview 61
9 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL 63
9.1 Overview 63
10 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY REGION 65
10.1 Overview 65
10.2 NORTH AMERICA 66
10.3 europe 69
10.4 asia pacific 71
10.5 South America 74
10.6 Middle East & Africa 77
11 COMPETITIVE LANDSCAPE 81
11.1 Introduction 81
11.2 Market Share Analysis, 2025 81
11.3 competitor dashboard 82
11.4 Public Players Stock Summary 83
11.5 Comparative Analysis: Key Players Financial 83
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 84
11.6.1 PRODUCT LAUNCH 84
11.6.2 PARTNERSHIP 84
11.6.3 LABELLING 85
11.6.4 PRODUCT EXPANSION 85
11.6.5 ACQUISITION 85
12 COMPANY PROFILES 86
12.1 CIPLA 86
12.1.1 COMPANY OVERVIEW 86
12.1.2 FINANCIAL OVERVIEW 87
12.1.3 PRODUCTS OFFERED 88
12.1.4 KEY DEVELOPMENTS 88
12.1.5 SWOT ANALYSIS 89
12.1.6 KEY STRATEGIES 89
12.2 Abbott 90
12.2.1 COMPANY OVERVIEW 90
12.2.2 FINANCIAL OVERVIEW 91
12.2.3 PRODUCTS OFFERED 91
12.2.4 KEY DEVELOPMENTS 92
12.2.5 SWOT ANALYSIS 93
12.2.6 KEY STRATEGIES 93
12.3 Sun Pharmaceutical Industries Ltd. 94
12.3.1 COMPANY OVERVIEW 94
12.3.2 FINANCIAL OVERVIEW 95
12.3.3 PRODUCTS OFFERED 96
12.3.4 KEY DEVELOPMENTS 96
12.3.5 SWOT ANALYSIS 96
12.3.6 KEY STRATEGIES 97
12.4 Dr. Reddy’s Laboratories Ltd. 98
12.4.1 COMPANY OVERVIEW 98
12.4.2 FINANCIAL OVERVIEW 99
12.4.3 PRODUCTS OFFERED 99
12.4.4 KEY DEVELOPMENTS 100
12.4.5 SWOT ANALYSIS 100
12.4.6 KEY STRATEGIES 101
12.5 Unilever 102
12.5.1 COMPANY OVERVIEW 102
12.5.2 FINANCIAL OVERVIEW 103
12.5.3 PRODUCTS OFFERED 103
12.5.4 KEY DEVELOPMENTS 104
12.5.5 SWOT ANALYSIS 105
12.5.6 KEY STRATEGIES 105
12.6 MANKIND PHARMA 106
12.6.1 COMPANY OVERVIEW 106
12.6.2 FINANCIAL OVERVIEW 107
12.6.3 PRODUCTS OFFERED 107
12.6.4 KEY DEVELOPMENTS 107
12.6.5 KEY STRATEGIES 108
12.7 Prestige Consumer Healthcare Inc. 109
12.7.1 COMPANY OVERVIEW 109
12.7.2 FINANCIAL OVERVIEW 110
12.7.3 PRODUCTS OFFERED 110
12.7.4 KEY DEVELOPMENTS 110
12.7.5 KEY STRATEGIES 111
12.8 Otsuka Holdings Co., Ltd. 112
12.8.1 COMPANY OVERVIEW 112
12.8.2 FINANCIAL OVERVIEW 113
12.8.3 PRODUCTS OFFERED 113
12.8.4 KEY DEVELOPMENTS 114
12.8.5 KEY STRATEGIES 114
12.9 FDC Limited 115
12.9.1 COMPANY OVERVIEW 115
12.9.2 FINANCIAL OVERVIEW 116
12.9.3 PRODUCTS OFFERED 116
12.9.4 KEY DEVELOPMENTS 117
12.9.5 KEY STRATEGIES 117
12.10 Wallace Pharmaceuticals 118
12.10.1 COMPANY OVERVIEW 118
12.10.2 FINANCIAL OVERVIEW 118
12.10.3 PRODUCTS OFFERED 118
12.10.4 KEY DEVELOPMENTS 119
12.10.5 KEY STRATEGIES 119
13 DATA CITATIONS 120

COMPANIES MENTIONED
Abbott, Cipla, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Ltd., Unilever, Mankind Pharma, Prestige Consumer, Healthcare Inc, Otsuka Holdings Co., Ltd, FDC Limited, Wallace Pharmaceuticals

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: STRUCTURE 19
FIGURE 2 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 37
FIGURE 3 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET DRIVER: IMPACT ANALYSIS 40
FIGURE 4 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET RESTRAINT: IMPACT ANALYSIS 42
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET 44
FIGURE 6 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, FORMULATION SEGMENT
ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 57
FIGURE 7 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, AGE GROUP SEGMENT
ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 59
FIGURE 8 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, APPLICATION SEGMENT
ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 61
FIGURE 9 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 63
FIGURE 10 NORTH AMERICA MARKET ANALYSIS: ORAL REHYDRATION SOLUTION (ORS) MARKET, 2019-2035 (USD MILLION) 66
FIGURE 11 EUROPE MARKET ANALYSIS: ORAL REHYDRATION SOLUTION (ORS) MARKET, 2019-2035 (USD MILLION) 69
FIGURE 12 ASIA-PACIFIC MARKET ANALYSIS: ORAL REHYDRATION SOLUTION (ORS) MARKET, 2019-2035 (USD MILLION) 71
FIGURE 13 SOUTH AMERICA MARKET ANALYSIS: ORAL REHYDRATION SOLUTION (ORS) MARKET, 2019-2035 (USD MILLION) 74
FIGURE 14 MIDDLE EAST AND AFRICA MARKET ANALYSIS: ORAL REHYDRATION SOLUTION (ORS) MARKET, 2019-2035 (USD MILLION) 77
FIGURE 15 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 81
FIGURE 16 COMPETITOR DASHBOARD: GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET 82
FIGURE 17 CIPLA: FINANCIAL OVERVIEW SNAPSHOT 87
FIGURE 18 CIPLA: SWOT ANALYSIS 89
FIGURE 19 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 91
FIGURE 20 ABBOTT: SWOT ANALYSIS 93
FIGURE 21 SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 95
FIGURE 22 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS 96
FIGURE 23 DR. REDDY’S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT 99
FIGURE 24 DR. REDDY’S LABORATORIES LTD.: SWOT ANALYSIS 100
FIGURE 25 UNILEVER: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 26 UNILEVER: SWOT ANALYSIS 105
FIGURE 27 MANKIND PHARMA: FINANCIAL OVERVIEW SNAPSHOT 107
FIGURE 28 PRESTIGE CONSUMER HEALTHCARE INC.: FINANCIAL OVERVIEW SNAPSHOT 110
FIGURE 29 OTSUKA HOLDINGS CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT 113
FIGURE 30 FDC LIMITED: FINANCIAL OVERVIEW SNAPSHOT 116

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 33
TABLE 2 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 58
TABLE 3 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 60
TABLE 4 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 62
TABLE 5 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 64
TABLE 6 GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET, BY REGION, 2019-2035 (USD MILLION) 65
TABLE 7 NORTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 66
TABLE 8 NORTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 67
TABLE 9 NORTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 67
TABLE 10 NORTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 68
TABLE 11 EUROPE ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 69
TABLE 12 EUROPE ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 70
TABLE 13 EUROPE ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 70
TABLE 14 EUROPE ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 70
TABLE 15 ASIA PACIFIC ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 71
TABLE 16 ASIA PACIFIC ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 72
TABLE 17 ASIA PACIFIC ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 72
TABLE 18 ASIA PACIFIC ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 73
TABLE 19 SOUTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 74
TABLE 20 SOUTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 75
TABLE 21 SOUTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 75
TABLE 22 SOUTH AMERICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 76
TABLE 23 MIDDLE EAST & AFRICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY FORMULATION, 2019-2035 (USD MILLION) 77
TABLE 24 MIDDLE EAST & AFRICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY AGE GROUP, 2019-2035 (USD MILLION) 78
TABLE 25 MIDDLE EAST & AFRICA ORAL REHYDRATION SOLUTION (ORS) MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78
TABLE 26 MIDDLE EAST & AFRICA ORAL REHYDRATION SOLUTION (ORS) MARKET,
BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION) 79
TABLE 27 PRODUCT LAUNCH 84
TABLE 28 PARTNERSHIP 84
TABLE 29 LABELLING 85
TABLE 30 PRODUCT EXPANSION 85
TABLE 31 ACQUISITION 85
TABLE 32 CIPLA: PRODUCTS OFFERED 88
TABLE 33 CIPLA: KEY DEVELOPMENTS 88
TABLE 34 ABBOTT: PRODUCTS OFFERED 91
TABLE 35 ABBOTT: KEY DEVELOPMENTS 92
TABLE 36 SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED 96
TABLE 37 DR. REDDY’S LABORATORIES LTD.: PRODUCTS OFFERED 99
TABLE 38 UNILEVER: PRODUCTS OFFERED 103
TABLE 39 UNILEVER: KEY DEVELOPMENTS 104
TABLE 40 MANKIND PHARMA: PRODUCTS OFFERED 107
TABLE 41 PRESTIGE CONSUMER HEALTHCARE INC.: PRODUCTS OFFERED 110
TABLE 42 OTSUKA HOLDINGS CO., LTD.: PRODUCTS OFFERED 113
TABLE 43 OTSUKA HOLDINGS CO., LTD.: KEY DEVELOPMENTS 114
TABLE 44 FDC LIMITED: PRODUCTS OFFERED 116
TABLE 45 WALLACE PHARMACEUTICALS: PRODUCTS OFFERED 118